Literature DB >> 22445468

GSTT1 gene abnormality in minimal change nephrotic syndrome with elevated serum immunoglobulin E.

Kohei Miyazaki1, Keisuke Sugimoto, Shoji Tsuji, Anna Iharada, Shinsuke Fujita, Hidehiko Yanagida, Naoki Sakata, Mitsuru Okada, Kazunari Kaneko, Tsukasa Takemura.   

Abstract

INTRODUCTION: Imbalance between T-helper 1 (Th1) and 2 (Th2) lymphocytes and effects of reactive oxygen species (ROS) upon glomerular capillary walls have been implicated in minimal change nephrotic syndrome (MCNS).
METHODS: By polymerase chain reaction and comparative genomic hybridization, we evaluated mutations of the GSTT1 gene (GSTT1), a member of the glutathione S-transferase (GST) supergene family associated with both protection of cells from ROS and control of allergic reactions and serum immunoglobulin (Ig) E.
RESULTS: Among 15 children with MCNS, IgE elevation (over 2,000 IU/l) and GSTT1 deletion was found in 2 who showed severe allergic symptoms. Serum ROS concentrations in these 2 patients were significantly higher than in healthy controls or other MCNS patients. In addition, a Th2 shift caused by increased serum interleukin (IL)- 4 was observed.
CONCLUSION: These results suggest presence of a GSTT1 abnormality in some children with MCNS having marked serum IgE elevations and various allergic complications. Defective ROS degradation and Th1/Th2 imbalance caused by GSTT1 abnormality could initiate proteinuria leading to MCNS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445468     DOI: 10.5414/cn107187

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.

Authors:  Yoei Miyabe; Takashi Takei; Yuko Iwabuchi; Takahito Moriyama; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2015-07-03       Impact factor: 2.801

2.  Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment.

Authors:  Yuko Iwabuchi; Takashi Takei; Takahito Moriyama; Mitsuyo Itabashi; Kosaku Nitta
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

3.  Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders.

Authors:  Yoichi Oshima; Keiichi Sumida; Masayuki Yamanouchi; Noriko Hayami; Akinari Sekine; Hiroki Mizuno; Masahiro Kawada; Rikako Hiramatsu; Eiko Hasegawa; Tatsuya Suwabe; Junichi Hoshino; Naoki Sawa; Takeshi Fujii; Kenmei Takaichi; Yoshifumi Ubara
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

4.  Increased number and activation of peripheral basophils in adult-onset minimal change disease.

Authors:  Huanqin Han; Yong-Zhi Xu; Shuzhen Liao; Haiyan Xiao; Xiaoqun Chen; Xing Lu; Shujun Wang; Chen Yang; Hua-Feng Liu; Qingjun Pan
Journal:  J Cell Mol Med       Date:  2020-06-08       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.